In Silico and 3D QSAR Studies of Natural Based Derivatives as Xanthine Oxidase Inhibitors

Curr Top Med Chem. 2019;19(2):123-138. doi: 10.2174/1568026619666190206122640.

Abstract

Background: A large number of disorders and their symptoms emerge from deficiency or overproduction of specific metabolites has drawn the attention for the discovery of new therapeutic agents for the treatment of disorders. Various approaches such as computational drug design have provided the new methodology for the selection and evaluation of target protein and the lead compound mechanistically. For instance, the overproduction of xanthine oxidase causes the accumulation of uric acid which can prompt gout.

Objective: In the present study we critically discussed the various techniques such as 3-D QSAR and molecular docking for the study of the natural based xanthine oxidase inhibitors with their mechanistic insight into the interaction of xanthine oxidase and various natural leads.

Conclusion: The computational studies of deferent natural compounds were discussed as a result the flavonoids, anthraquinones, xanthones shown the remarkable inhibitory potential for xanthine oxidase inhibition moreover the flavonoids such as hesperidin and rutin were found as promising candidates for further exploration.

Keywords: 3D QSAR; CADD; Flavonoids; In silico docking; Natural derivatives; Xanthine oxidase..

Publication types

  • Review

MeSH terms

  • Anthraquinones / chemistry
  • Biological Products / antagonists & inhibitors*
  • Biological Products / chemistry
  • Biological Products / pharmacology*
  • Coenzymes / chemistry
  • Computer Simulation
  • Computer-Aided Design
  • Drug Design
  • Enzyme Inhibitors / chemistry*
  • Enzyme Inhibitors / pharmacology*
  • Flavin-Adenine Dinucleotide / chemistry
  • Flavonoids / chemistry
  • Iron-Sulfur Proteins / chemistry
  • Metalloproteins / chemistry
  • Molecular Docking Simulation
  • Molybdenum Cofactors
  • Protein Conformation
  • Pteridines / chemistry
  • Quantitative Structure-Activity Relationship
  • Xanthine Oxidase / antagonists & inhibitors*
  • Xanthine Oxidase / biosynthesis
  • Xanthine Oxidase / chemistry
  • Xanthine Oxidase / pharmacology*
  • Xanthones / chemistry

Substances

  • Anthraquinones
  • Biological Products
  • Coenzymes
  • Enzyme Inhibitors
  • Flavonoids
  • Iron-Sulfur Proteins
  • Metalloproteins
  • Molybdenum Cofactors
  • Pteridines
  • Xanthones
  • Flavin-Adenine Dinucleotide
  • molybdenum cofactor
  • Xanthine Oxidase